148 participants
ONC-392 Plus Lutetium Lu 177 Vipivotide Tetraxetan in Patients With mCRPC
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2026-05-22
- Start Date:
- 2023-12-11
- Completion:
- 2026-11-30
Conditions
- Metastatic Castration-resistant Prostate Cancer
Interventions
- DRUG
No Results Yet